Resource Center

Media

Upcoming Webinar July 16 - From Bench to Bedside: Cracking the Code of Infection with Metagenomic Sequencing. RSVP here

From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections.

Karius

Clinician Presentations

center

This webinar highlights findings from a large-scale retrospective study at Baylor St. Luke's Medical Center, evaluating the clinical impact of microbial cell-free DNA (mcfDNA) sequencing in solid organ transplant (SOT) recipients. This webinar provides insight into the evolving landscape of infection risks in SOT patients, and how mcfDNA testing can address diagnostic challenges in cases like fever of unknown origin, complicated pneumonia, and invasive fungal infections. The session also demonstrates how the test’s rapid turnaround and comprehensive pathogen detection may contribute to better clinical outcomes.

Professors of Medicine, Infectious Diseases, Baylor College of Medicine

Uncovering Infections in Transplant Recipients: Clinical Utility of Microbial Cell-Free DNA Metagenomic Sequencing

Medical Director, OSF System Microbiology, Immunology & Molecular Diagnostics Lab

CAP Today Webinar - April 2025

This webinar explores the application of metagenomic sequencing of plasma microbial cell-free DNA for the detection of pathogens associated with febrile neutropenia. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including fever of unknown origin, invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia. Our featured speaker, Dr. Negar Ashouri, reviews some of the published data and shares insights on the optimal use of the Karius Test for febrile neutropenia. Dr. Ashouri also shares some of her own patient cases describing the clinical impact of the Karius Test in febrile neutropenia.

Director, Antimicrobial Stewardship Chair, Infection Prevention Committee, Children's Hospital of Orange County

The Power of Microbial Cell-Free DNA: Real World Application of A Liquid Biopsy for Febrile Neutropenia

Listen to this lively discussion from a panel of leading infectious disease specialists on optimal implementation and utilization of metagenomic sequencing of microbial cell-free DNA. During this event the panel explores the comparative benefits of the Karius Test to traditional methods and emphasizes how this test has complimented and enhanced their diagnostic workflows. The panel also shares their personal experiences describing how the Karius Test has helped to improve clinical outcomes for their most vulnerable patients across a variety of use cases and patient populations.

Harnessing Microbial Insights: How Metagenomic Sequencing of Microbial Cell-Free DNA is Transforming Infectious Disease Diagnostics

This webinar will explore the application of metagenomic next-generation sequencing of plasma microbial cell-free DNA for the detection of pathogens associated with fever of unknown origin. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including fever of unknown origin, invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia.

Our featured speaker, Dr. Jaime Fergie, a pediatric infectious disease specialist, will review some of the published data and share his own insights on the optimal utilization of the Karius Test in fever of unknown origin.

Director Infectious Diseases, Driscoll Children's Hospital

The Power of Plasma Microbial Cell-Free DNA: Real World Application of a Liquid Biopsy for the Detection of Pathogens Associated with Fever of Unknown Origin

ASM 2024 Evening Event Panel - Unraveling the Mysteries of Infectious Diseases: The Role of Metagenomic Sequencing in Your Laboratory

This webinar will explore the application of metagenomic next-generation sequencing of plasma for the detection of invasive fungal infections. The Karius Test, a liquid biopsy for infectious diseases, utilizes a single blood sample to identify over 1000 pathogens for various diagnostic purposes, including invasive fungal infections, pneumonia, endocarditis, and febrile neutropenia. Our featured speaker, Dr. Martin Hoenigl, an infectious disease specialist and expert in the field of clinical mycology, will review some of the published data supporting use of the Karius Test for detection of pathogens associated with invasive fungal infections, including his own research on its diagnostic performance for COVID-19 associated pulmonary aspergillosis. He will also share insights on the optimal utilization of the Karius Test for invasive fungal infections.

Associate Professor of Translational Mycology, Division of Infectious Diseases - Medical University of Graz, Austria  Associate Professor of Medicine, Division of Infectious Diseases - University of California, San Diego (UCSD)